KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer
about
rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese populationCoexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancerImportant molecular genetic markers of colorectal cancer.Elevated tumor-to-liver uptake ratio (TLR) from (18)F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.The current status of treatment for colorectal cancer in China: A systematic review.KRAS biomarker testing disparities in colorectal cancer patients in New Mexico.
P2860
Q36212703-EE4AF587-0271-45BF-94ED-28EB3DC22AA0Q37608405-9AFB2B25-69B1-432C-B852-F5378EB377D4Q37619856-DAF5EE62-F51D-4F27-9389-6080B31D3E6AQ38622719-CD89EDD5-3151-4268-909D-D66483606961Q38698206-57E61287-47F7-4630-83C8-C2D7541D6686Q47100034-4F746887-DB1A-4A5D-AF6C-2338D1AD3E88Q47137265-93AAF5AA-8845-48D4-B64E-D971055E195C
P2860
KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
KRAS as a predictor of poor pr ...... e II and III colorectal cancer
@en
type
label
KRAS as a predictor of poor pr ...... e II and III colorectal cancer
@en
prefLabel
KRAS as a predictor of poor pr ...... e II and III colorectal cancer
@en
P2093
P2860
P1433
P1476
KRAS as a predictor of poor pr ...... e II and III colorectal cancer
@en
P2093
Dianke Chen
George P Kim
Jianping Wang
Shuyun Tan
Yanhong Deng
P2860
P304
P356
10.1016/J.MOLONC.2015.03.006
P577
2015-03-27T00:00:00Z